Aprotinin-associated risks in off-pump coronary artery bypass grafting

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 8, 2009, Pages 455-459

  Bittner, H B ^a   Lange, M ^a   Lemke, J ^a   Rastan, A ^a   Mohr, F W ^a  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

Author keywords

Antifibrinolytic treatment; Aprotinin; Complications; Offpump coronary artery bypass grafting; Safety

Indexed keywords

APROTININ; CLOPIDOGREL; DOPAMINE; ENOXIMONE; HEPARIN; PROTAMINE SULFATE;

AGED; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; STERNOTOMY;

AGED; APROTININ; CORONARY ARTERY BYPASS, OFF-PUMP; CREATINE KINASE; FEMALE; HEMOSTATICS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STERNOTOMY; TREATMENT OUTCOME;

EID: 72949094273     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1186067     Document Type: Conference Paper

References (24)

1. Sedrakyan A, Treasure T, Elefteriades J A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004 128 442-448
2. Henry D A., Carless P A., Moxey A J. et al. Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007 (4) CD001886
3. Englberger L, Markart P, Eckstein F S., Immer F F., Berdat P A., Carrel T P. Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery. Eur J Cardiothorac Surg 2002 22 545-551
4. Vanek T, Jares M, Fajt R et al. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). Eur J Cardiothorac Surg 2005 28 563-568
5. Poston R S., White C, Gu J et al. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Ann Thorac Surg 2006 81 104-111
6. Bittner H B., Lange M, Lemke J, Rastan A, Mohr F W. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting. Ann Thorac Surg 2008 85 1662-1668
7. Mangano D T., Tudor J C., Dietzel C. The risk associated with aprotinin in cardiac surgery. New Eng J Med 2006 354 353-365
8. Mangano D T., Miao Y, Vuylsteke A et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007 297 471-479
9. Ferraris V A., Bridges C R., Anderson R P. Aprotinin in cardiac surgery. N Engl J Med 2006 354 1953-1954
10. Sedrakyan A, Atkins D, Treasure T. The risk of aprotinin: a conflict of evidence. Lancet 2006 367 1376-1377
11. Royston D, Chhatwani A. Safety aspects of aprotinin therapy in cardiac surgery patients. Expert Opin Drug Saf 2006 5 539-552
12. Mouton R, Finch D, Davies I, Binks A, Zacharowski K. Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study. Lancet 2008 371 475-482
13. Pagano D, Howell N J., Freemantle N et al. Bleeding in cardiac surgery: the use of aprotinin does not affect survival. J Thorac Cardiovasc Surg 2008 135 495-502
14. Fergusson D A., Hébert P C., Mazer C D. et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New Engl J Med 2008 358 2319-2331
15. Dietrich W, Ebell A, Busley R, Boulesteix A-L. Aprotinin and anaphylaxis: analysis of 12403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 2007 84 1144-1150
16. Levey A S., Greene T, Kusek J W., Beck G L., MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000 11 A0828
17. Alderman E L., Levy J H., Rich J B. et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998 116 716-730
18. Poston R S., Gu J, White C et al. Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin. Transfusion 2008 48 39S-46S
19. Sear J W. Kidney dysfunction in the postoperative period. Br J Anaesth 2005 95 20-32
20. Chertow G M., Lazarus J M., Christiansen C L. et al. Preoperative renal risk stratification. Circulation 1997 95 878-884
21. Godet G, Fléron M-H, Vicaut E et al. Risk factors for acute postoperative renal failure in thoracic or thoracoabdominal aortic surgery: a prospective study. Anesth Analg 1997 85 1227-1232
22. Conlon P J., Stafford-Smith M, White W D. et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant 1999 14 1158-1162
23. O'Connor C J., Brown D V., Avramov M, Barnes S, O'Connor H N., Tuman K J. The impact of renal dysfunction on aprotinin pharmacokinetics during cardiopulmonary bypass. Anesth Analg 1999 89 1101-1107
24. Sedrakyan A, Wu A W., Parashar A, Bass E B., Treasure T. Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting. A meta-analysis of systematically reviewed trials. Stroke 2006 37 2759-2769